Streetbeat News

Analyst Ratings

THC

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Tenet Healthcare (NYSE:THC) and maintained a price target of $168.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 3:23 pm

PGNY

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Progyny (NASDAQ:PGNY) and maintained a $25 price target.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 3:21 pm

HPQ

HP shares declined following a downgrade by Citigroup from Buy to Neutral, with the price target maintained at $37.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 3:21 pm

RIOT

Bernstein has raised its price target for Riot Platforms (NASDAQ:RIOT) to $22, maintaining an 'Outperform' rating. The optimistic forecast is based on Riot's strategic focus on Bitcoin mining, its extensive power capacity, and its positioning in the cryptocurrency market. Riot is building the world's largest Bitcoin mining data center in Texas, aiming for a 1-gigawatt power capacity. By 2025, Riot is expected to control 8% of the Bitcoin network. Bernstein projects Riot's revenue to grow at a 149.6% CAGR from 2023 to 2025, with an EBITDA of approximately $1.1 billion in 2025.

Portfolio Pulse from Murtuza Merchant

October 01, 2024 | 3:18 pm

MOH

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Molina Healthcare (NYSE:MOH) and maintained a price target of $406.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 3:17 pm

BIDU

Investors are showing a mixed but generally bullish sentiment on Baidu (NASDAQ:BIDU) through options trading. Benzinga's options scanner detected 16 unusual trades, with a focus on a price range between $87 and $135. Analysts have mixed ratings, with price targets around $100-$105.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 3:16 pm

NOW

ServiceNow has seen a surge in options trading, with a bearish sentiment prevailing among investors. The stock is currently down 1.69% at $879.31, and experts have set a price target of $900. Recent options trades show a mix of bullish and bearish positions, with a focus on a price range of $760 to $1200.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 3:16 pm

HUM

Cantor Fitzgerald analyst Sarah James has reiterated a Neutral rating on Humana (NYSE:HUM) and maintained a price target of $395.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 3:10 pm

HCA

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on HCA Healthcare and maintained a price target of $392.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 3:08 pm

ELV

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a price target of $600.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 3:02 pm